Chemotherapy-induced peripheral neuropathy (CIPN) is a nerve-damaging side effect of antineoplastic drugs used in chemotherapy, which is a popular cancer treatment. Between 30 & 40 % of people having chemotherapy develop CIPN.
The global analytical standards market generated a revenue of US$ 1,620.4 million in 2022 and is estimated to record a revenue of US$ 2,837.1 million by 2031, growing at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2031.
Global respiratory syncytial virus market was valued at US$ 2,331.3 million in 2023 and is projected to surpass the market valuation of US$ 8,137.2 million by 2032, growing at a CAGR of 14.9% over the forecast period 2024-2032.
The Global Idiopathic Pulmonary Fibrosis Market generated US$ 1,915.0 million in 2020 and is estimated to reach US$ 4,298.8 million by 2030, growing at a compound annual growth rate (CAGR) of 9.4%.
Peripheral neuropathy itself includes a collection of several types with diverse signs and symptoms. The research report of the Peripheral neuropathy market also includes a detailed analysis of market segmentation, competitive landscape, market vendors, and estimated market size in qualitative and quantitative methods.